• LOGIN
    Login with username and password
Repository logo

BORIS Portal

Bern Open Repository and Information System

  • Publications
  • Theses
  • Research Data
  • Projects
  • Organizations
  • Researchers
  • More
  • Collections
  • Statistics
  • LOGIN
    Login with username and password
Repository logo
Unibern.ch
  1. Home
  2. Publications
  3. Increased Receptor Affinity and Reduced Recognition by Specific Antibodies Contribute to Immune Escape of SARS-CoV-2 Variant Omicron.
 

Increased Receptor Affinity and Reduced Recognition by Specific Antibodies Contribute to Immune Escape of SARS-CoV-2 Variant Omicron.

Options
  • Details
  • Files
BORIS DOI
10.48350/170317
Publisher DOI
10.3390/vaccines10050743
PubMed ID
35632499
Description
In this report, we mechanistically reveal how the Variant of Concern (VOC) SARS-CoV-2 Omicron (B.1.1.529) escapes neutralizing antibody responses, by physio-chemical characterization of this variant in comparison to the wild-type Wuhan and the Delta variant (B.1.617.2). Convalescent sera, as well as sera obtained from participants who received two or three doses of mRNA vaccines (Moderna-mRNA-1273® or Pfizer-BNT162b2®), were used for comparison in this study. Our data demonstrate that both Delta, as well as Omicron variants, exhibit a higher affinity for the receptor ACE2, facilitating infection and causing antibody escape by receptor affinity (affinity escape), due to the reduced ability of antibodies to compete with RBD-receptor interaction and virus neutralization. In contrast, only Omicron but not the Delta variant escaped antibody recognition, most likely because only Omicron exhibits the mutation at E484A, a position associated with reduced recognition, resulting in further reduced neutralization (specificity escape). Nevertheless, the immunizations with RNA-based vaccines resulted in marked viral neutralization in vitro for all strains, compatible with the fact that Omicron is still largely susceptible to vaccination-induced antibodies, despite affinity- and specificity escape.
Date of Publication
2022-05-09
Publication Type
Article
Subject(s)
600 Technology > 610 Medicine & health
Keyword(s)
Delta Omicron SARS-CoV-2 antibody
Language(s)
en
Contributor(s)
Vogt, Anne-Cathrine Sarah
Universitätsklinik für Rheumatologie und Immunologie
Department for BioMedical Research, Forschungsgruppe Rheumatologie
Sousa Augusto, Gilles Anderson
Universitätsklinik für Rheumatologie und Immunologie
Department for BioMedical Research, Forschungsgruppe Rheumatologie
Martina, Byron
Chang, Xinyue
Department for BioMedical Research, Forschungsgruppe Rheumatologie
Universitätsklinik für Rheumatologie und Immunologie
Nasrallah, Gheyath
Speiser, Daniel Ernst
Universitätsklinik für Rheumatologie und Immunologie
Department for BioMedical Research, Forschungsgruppe Rheumatologie
Vogel, Monique
Universitätsklinik für Rheumatologie und Immunologie
Department for BioMedical Research, Forschungsgruppe Rheumatologie
Bachmann, Martin
Universitätsklinik für Rheumatologie und Immunologie
Department for BioMedical Research, Forschungsgruppe Rheumatologie
Mohsen, Mona Omar Mahmoud
Universitätsklinik für Rheumatologie und Immunologie
Department for BioMedical Research, Forschungsgruppe Rheumatologie
Additional Credits
Universitätsklinik für Rheumatologie und Immunologie
Department for BioMedical Research, Forschungsgruppe Rheumatologie
Series
Vaccines
Publisher
MDPI
ISSN
2076-393X
Access(Rights)
open.access
Show full item
BORIS Portal
Bern Open Repository and Information System
Build: dd892c [ 9.04. 8:30]
Explore
  • Projects
  • Funding
  • Publications
  • Research Data
  • Organizations
  • Researchers
  • Audiovisual Material
  • Software & other digital items
  • Events
More
  • About BORIS Portal
  • Send Feedback
  • Cookie settings
  • Service Policy
Follow us on
  • Mastodon
  • YouTube
  • LinkedIn
UniBe logo